The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a cost-plus-fixed-fee definitive contract to The Johns Hopkins University Applied Physics Laboratory LLC (APL), a not-for-profit university-affiliated research center, to develop "Next Generation Microfluidic Antisera Neutralization Assays." The $832,560.00 contract does not have a set-aside designation and was awarded on September 30, 2019, with a completion date of September 29, 2021. APL, which does business as "APL," has a long history of providing critical research and development services to federal agencies, including the Department of Defense, Department of Homeland Security, and National Aeronautics and Space Administration. As a research arm of The Johns Hopkins University, APL has significant expertise in areas like defense technology, space science, biomedicine, and more, which it leverages to support national security and scientific missions through prime and subcontract awards.
Generated 3/22/24, 12:46 AM